Works by Hiroaki Itamochi


Results: 67
    1

    Alteration of telomerase activity in ovarian cancer after chemotherapy.

    Published in:
    2000
    By:
    • Takahashi, Masakuni;
    • Kigawa, Junzo;
    • Oishi, Tetsuro;
    • Itamochi, Hiroaki;
    • Shimada, Muneaki;
    • Sato, Shinya;
    • Kamazawa, Shunji;
    • Akeshima, Ryouji;
    • Terakawa, Naoki;
    • Takahashi, M;
    • Kigawa, J;
    • Oishi, T;
    • Itamochi, H;
    • Shimada, M;
    • Sato, S;
    • Kamazawa, S;
    • Akeshima, R;
    • Terakawa, N
    Publication type:
    journal article
    2
    3
    4
    5
    6

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.

    Published in:
    Supportive Care in Cancer, 2014, v. 22, n. 11, p. 2891, doi. 10.1007/s00520-014-2280-6
    By:
    • Takeshima, Nobuhiro;
    • Matoda, Maki;
    • Abe, Masakazu;
    • Hirashima, Yasuyuki;
    • Kai, Kentaro;
    • Nasu, Kaei;
    • Takano, Masashi;
    • Furuya, Kenichi;
    • Sato, Seiya;
    • Itamochi, Hiroaki;
    • Tsubamoto, Hiroshi;
    • Hasegawa, Kosei;
    • Terao, Kiminari;
    • Otsuki, Takeo;
    • Kuritani, Keiko;
    • Ito, Kimihiko
    Publication type:
    Article
    16
    17
    18

    Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G<sub>2</sub>/M phase in ovarian cancer.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72174-9
    By:
    • Murakami, Yuichi;
    • Katsuchi, Daisuke;
    • Matsumoto, Taichi;
    • Kanazawa, Kuon;
    • Shibata, Tomohiro;
    • Kawahara, Akihiko;
    • Akiba, Jun;
    • Yanaihara, Nozomu;
    • Okamoto, Aikou;
    • Itamochi, Hiroaki;
    • Sugiyama, Toru;
    • Terada, Atsumu;
    • Nishio, Shin;
    • Tsuda, Naotake;
    • Kato, Kiyoko;
    • Ono, Mayumi;
    • Kuwano, Michihiko
    Publication type:
    Article
    19
    20

    Predicting time to ovarian carcinoma recurrence using protein markers.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3740, doi. 10.1172/JCI68509
    By:
    • Ji-Yeon Yang;
    • Kosuke Yoshihara;
    • Kenichi Tanaka;
    • Masayuki Hatae;
    • Hideaki Masuzaki;
    • Hiroaki Itamochi;
    • Masashi Takano;
    • Kimio Ushijima;
    • Tanyi, Janos L.;
    • Coukos, George;
    • Yiling Lu;
    • Mills, Gordon B.;
    • Verhaak, Roel G. W.
    Publication type:
    Article
    21
    22
    23

    Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 3, p. 247, doi. 10.1007/s00280-003-0714-9
    By:
    • Sato, Shinya;
    • Kigawa, Junzo;
    • Kanamori, Yasunobu;
    • Itamochi, Hiroaki;
    • Oishi, Tetsuro;
    • Shimada, Muneaki;
    • Iba, Takahiro;
    • Naniwa, Jun;
    • Uegaki, Kazunori;
    • Terakawa, Naoki
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group.

    Published in:
    International Journal of Clinical Oncology, 2013, v. 18, n. 6, p. 1107, doi. 10.1007/s10147-012-0483-8
    By:
    • Oshita, Takafumi;
    • Itamochi, Hiroaki;
    • Nishimura, Ryuichiro;
    • Numa, Fumitaka;
    • Takehara, Kazuhiro;
    • Hiura, Masamichi;
    • Tanimoto, Hirotoshi;
    • Noma, Jun;
    • Hayase, Ryoji;
    • Murakami, Akihiro;
    • Fujimoto, Hideo;
    • Kanamori, Yasunobu;
    • Kitada, Fuminori;
    • Shitsukawa, Keiji;
    • Nagaji, Makoto;
    • Minagawa, Yukihisa;
    • Fujiwara, Michihisa;
    • Kigawa, Junzo
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Measurement of endometrial thickness in premenopausal women in office gynecology.

    Published in:
    Reproductive Medicine & Biology, 2018, v. 17, n. 1, p. 29, doi. 10.1002/rmb2.12062
    By:
    • Tsuda, Hiroshi;
    • Ito, Yoichi M.;
    • Todo, Yukiharu;
    • Iba, Takahiro;
    • Tasaka, Keiichi;
    • Sutou, Yuji;
    • Hirai, Kozo;
    • Dozono, Koichiro;
    • Dobashi, Yoshifusa;
    • Manabe, Mami;
    • Sakamoto, Tomomi;
    • Yamamoto, Ritsu;
    • Ueda, Katsufumi;
    • Akatsuka, Moe;
    • Kiyozuka, Yasuhiko;
    • Nagai, Nobutaka;
    • Imai, Manami;
    • Kobiki, Koji;
    • Fujita, Hiromasa;
    • Itamochi, Hiroaki
    Publication type:
    Article
    39
    40
    41

    An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.

    Published in:
    2018
    By:
    • Shoji, Tadahiro;
    • Komiyama, Shinichi;
    • Kigawa, Junzo;
    • Tanabe, Hiroshi;
    • Kato, Kazuyoshi;
    • Itamochi, Hiroaki;
    • Fujiwara, Hiroyuki;
    • Kamiura, Shoji;
    • Hamano, Tetsutaro;
    • Sugiyama, Toru;
    • for the Japanese Gynecologic Oncology Group;
    • Japanese Gynecologic Oncology Group
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47
    48

    Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.

    Published in:
    Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0018-2
    By:
    • Tamura, Ryo;
    • Yoshihara, Kosuke;
    • Saito, Tetsuya;
    • Ishimura, Ryosuke;
    • Martínez-Ledesma, Juan Emmanuel;
    • Xin, Hu;
    • Ishiguro, Tatsuya;
    • Mori, Yutaro;
    • Yamawaki, Kaoru;
    • Suda, Kazuaki;
    • Sato, Seiya;
    • Itamochi, Hiroaki;
    • Motoyama, Teiichi;
    • Aoki, Yoichi;
    • Okuda, Shujiro;
    • Casingal, Cristine R.;
    • Nakaoka, Hirofumi;
    • Inoue, Ituro;
    • Verhaak, Roel G. W.;
    • Komatsu, Masaaki
    Publication type:
    Article
    49
    50